White Paper: Must-Know Finance Concepts for Life Sciences ValuationsThe "Must-Know Finance Concepts for Life Sciences Valuations, Part I" white paper is based on the webinar with the same title. If you would prefer to watch the video and listen along, click here. This white paper presents an introduction to the key concepts and most common methodologies applied when  evaluating life sciences assets. 

If you are an entrepreneur who is, or will be, raising financing, licensing an asset or selling your company, a private investor who wants to estimate and negotiate start-up share value, or any other professional who is active in the investing sector, you'll benefit from this overview of the key concepts used in life sciences valuation discussions.

Topics covered include:

  • The various valuation methodologies used to assign a value to life science businesses and assets
  • The methodologies used in particular by pharma partners and venture capitalists
  • An explanation of three fundamental concepts in valuation: risk-adjusted value, cost of capital and present value

If you find this white paper helpful, we encourage you to download the follow-up to this white paper series. Click here to download, "Must-Know Finance Concepts for Life Sciences Valuations, Part II."

Download
the white paper